Apo-Si Nature deal makers – November 2017

• Home
• About Us
  ▼
  • Our mission and vision
  • Scientific president
  • Team
  • Board of directors
  • Scientific advisory board
  • Intellectual property
• Our Technology
• Our Platform
• Investors
  ▼
  • Presentations
  • Financial Reports
  • Stock Information
• News Room
  ▼
  • Press release
  • Publications
• Other Projects
  ▼
  • ATT-11T: Anti cancer pro-drug
  • ML-10
• Contact Us